Anaerobic bacteria in 118 patients with deepspace head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria

被引:36
作者
Boyanova, Lyudmila
Kolarov, Rossen
Gergova, Galina
Deliverska, Elitsa
Madjarov, Jivko
Marinov, Milen
Mitov, Ivan
机构
[1] Med Univ Sofia, Dept Microbiol, Sofia 1431, Bulgaria
[2] Univ Hosp Maxillofacial Surg, Sofia, Bulgaria
关键词
IN-VITRO ACTIVITY; BETA-LACTAMASE PRODUCTION; ANTIMICROBIAL SUSCEPTIBILITY; PORPHYROMONAS; PREVOTELLA;
D O I
10.1099/jmm.0.46512-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of this study was to assess the incidence and susceptibility to antibacterial agents of anaerobic strains in 118 patients with head and neck abscesses (31) and cellulitis (87). Odontogenic infection was the most common identified source, occurring in 73 (77(.)7%) of 94 patients. The incidence of anaerobes in abscesses and cellulitis was 71 and 75(.)9%, respectively, and that in patients before (31 patients) and after (87) the start of empirical treatment was 80(.)6 and 72(.)4%, respectively. The detection rates of anaerobes in patients with odontogenic and other sources of infection were 82(.)2 and 71(.)4%, respectively. In total, 174 anaerobic strains were found, The predominant bacteria were Prevotella (49 strains), Fusobacterium species (22), Actinomyces spp. (21), anaerobic cocci (20) and Eubacterium spp. (118). Bacteroides fragilis strains were isolated from 7 (5(.)9%) specimens. The detection rate of Fusobacterium strains from non-treated patients (32(.)2%) was higher than that from treated patients (13(.)8%). Resistance rates to clinclamycin and metroniclazole of Gram-negative anaerobes were 5(.)4 and 2(.)5%, respectively, and those of Gram-positive species were 4(.)5 and 58(.)3%, respectively. One Prevotella strain was intermediately susceptible to ampicillin/sulbactam. In conclusion, the start of empirical treatment could influence the frequency or rate of isolation of Fusobacterium species. The involvement of the Bacteroides fragilis group in some head and neck infections should be considered.
引用
收藏
页码:1285 / 1289
页数:5
相关论文
共 20 条
[1]   Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].
Aldridge, KE ;
Ashcraft, D ;
Cambre, K ;
Pierson, CL ;
Jenkins, SG ;
Rosenblatt, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243
[2]  
[Anonymous], M11A6 NCCLS
[3]   Antimicrobial resistance and β-lactamase production of clinical isolates of Prevotella and Porphyromonas species [J].
Bahar, H ;
Torun, MM ;
Demirci, M ;
Kocazeybek, B .
CHEMOTHERAPY, 2005, 51 (01) :9-14
[4]   Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses [J].
Brook, I .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (12) :1545-1550
[5]   Susceptibility testing of anaerobic bacteria: Evaluation of the redesigned (Version 96) bioMerieux ATB ANA device [J].
Dubreuil, L ;
Houcke, I ;
Singer, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1824-1828
[6]   Streptococcus miller - An organism for head and neck infections and abscess [J].
Han, JK ;
Kerschner, JE .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2001, 127 (06) :650-654
[7]   Factors affecting the bacteriology of deep neck infection: a retrospective study of 128 patients [J].
Huang, TT ;
Tseng, FY ;
Yeh, H ;
Hsu, CJ ;
Chen, YS .
ACTA OTO-LARYNGOLOGICA, 2006, 126 (04) :396-401
[8]  
Jousimies-Somer H R., 2002, Wadsworth anaerobic bacteriology manual, V6th
[9]   In vitro activity of R-95867, the active metabolite of a new oral carbapenem, CS-834, against anaerobic bacteria [J].
Kato, N ;
Tanaka, K ;
Kato, H ;
Watanabe, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) :357-361
[10]   Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents [J].
Koeth, LM ;
Good, CE ;
Appelbaum, PC ;
Goldstein, EJC ;
Rodloff, AC ;
Claros, M ;
Dubreuil, LJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) :1039-1044